Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Samaneh Kalirai, Jasmina I Ivanova, Magaly Perez-Nieves, Judith J Stephenson, Irene Hadjiyianni, Michael Grabner, Roy Daniel Pollom, Caroline Geremakis, Beverly L Reed & Lawrence Fisher. (2020) Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States. Diabetes, Metabolic Syndrome and Obesity 13, pages 1023-1033.
Read now
Read now
Nagaaki Tanaka, Takeshi Kurose & Yutaka Seino. (2016) Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus. Current Medical Research and Opinion 32:9, pages 1477-1478.
Read now
Read now
Articles from other publishers (17)
Bernard H. Charbonnel, Hungta Chen, Javier Cid‐Ruzafa, Andrew Cooper, Peter Fenici, Marilia B. Gomes, Gabriela L. Saraiva, Jesús Medina, Antonio Nicolucci, Marina V. Shestakova, Iichiro Shimomura, Filip Surmont, Fengming Tang, Jiten Vora, Hirotaka Watada & Kamlesh Khunti. (2022)
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global
DISCOVER
study
. Diabetes, Obesity and Metabolism 25:1, pages 46-55.
Crossref
Crossref
Brenda Bongaerts, Bianca Kollhorst, Oliver Kuss, Iris Pigeot & Wolfgang Rathmann. (2021) Dispensation Patterns of Glucose-Lowering Drugs in Newly Diagnosed
Type 2 Diabetes: Routine Data Analysis of Insurance Claims in
Germany. Experimental and Clinical Endocrinology & Diabetes 130:09, pages 587-595.
Crossref
Crossref
Dominik Lautsch, Robert Boggs, Tongtong Wang, Claudio Gonzalez, Gary Milligan, Swapnil Rajpathak, Seema Malkani, Euan McLeod, James Carroll & Victoria Higgins. (2021) Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey. Advances in Therapy 39:2, pages 1016-1032.
Crossref
Crossref
Rory J. McCrimmon, Saud Al Sifri, Rifat Emral, Viswanathan Mohan, Leobardo Sauque‐Reyna, Carlos Trescolí, Nebojsa Lalic, Agustina Alvarez, Nacima Demil, Mathieu Coudert, Alka Shaunik, Mireille Bonnemaire & Julio Rosenstock. (2021)
Advancing therapy with
iGlarLixi
versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the
SoliMix
randomized controlled trial
. Diabetes, Obesity and Metabolism 23:6, pages 1221-1231.
Crossref
Crossref
A. Turchin, N. Hosomura, H. Zhang, S. Malmasi & M. Shubina. (2020) Predictors and consequences of declining insulin therapy by individuals with type 2 diabetes. Diabetic Medicine 37:5, pages 814-821.
Crossref
Crossref
Rajesh R. Mehta, Alison M. Edwards, Swapnil Rajpathak, Ajay Sharma, Kenneth J. Snow & Kristy Iglay. (2020) Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis. Journal of Clinical & Translational Endocrinology 19, pages 100215.
Crossref
Crossref
Irene Romera, Silvia Díaz, Antoni Sicras-Mainar, Flora López-Simarro, Tatiana Dilla, Esther Artime & Jesús Reviriego. (2019) Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study. Diabetes Therapy 11:2, pages 437-451.
Crossref
Crossref
Kristy Iglay, Baanie Sawhney, Alex Z. Fu, Gail Fernandes, Michael F. Crutchlow, Swapnil Rajpathak & Kamlesh Khunti. (2019) Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes. Endocrinology, Diabetes & Metabolism 3:1.
Crossref
Crossref
John P.H. Wilding, Una Rigney, Betina T. Blak, Stephen T. Nolan, Peter Fenici & Jesús Medina. (2019) Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 155, pages 107791.
Crossref
Crossref
John Wilding, Thomas Godec, Kamlesh Khunti, Stuart Pocock, Robin Fox, Liam Smeeth, Per Clauson, Peter Fenici, Niklas Hammar & Jesús Medina. (2018) Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Medicine 16:1.
Crossref
Crossref
Urvi Desai, Noam Y. Kirson, Jennifer Kim, Kamlesh Khunti, Sarah King, Erich Trieschman, Michael Hellstern, Phillip R. Hunt & Jayanti Mukherjee. (2018) Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care 41:10, pages 2096-2104.
Crossref
Crossref
Alexandra M. Mueller, Christoph R. Meier, Susan S. Jick & Cornelia Schneider. (2018) The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus. Pancreas 47:7, pages 807-815.
Crossref
Crossref
Samaneh Kalirai, Judith Stephenson, Magaly Perez-Nieves, Michael Grabner, Irene Hadjiyianni, Caroline Geremakis, Roy Daniel Pollom, Beverly Reed & Lawrence Fisher. (2018) Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus. Primary Care Diabetes 12:2, pages 155-162.
Crossref
Crossref
Kamlesh Khunti, Marilia B. Gomes, Stuart Pocock, Marina V. Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar & Jesús Medina. (2017) Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diabetes, Obesity and Metabolism 20:2, pages 427-437.
Crossref
Crossref
Manel Mata‐Cases, Josep Franch‐Nadal, Jordi Real, Mònica Gratacòs, Flora López‐Simarro, Kamlesh Khunti & Dídac Mauricio. (2017)
Therapeutic inertia in patients treated with two or more antidiabetics in primary care:
F
actors predicting intensification of treatment
. Diabetes, Obesity and Metabolism 20:1, pages 103-112.
Crossref
Crossref
Sandro Gentile, Antonio Ceriello, Giuseppe Pipicelli & Felice Strollo. (2017) Type 2 diabetes mellitus treatment habits in a specialized care setting: the START-DIAB study. Mediterranean Journal of Nutrition and Metabolism 10:2, pages 165-179.
Crossref
Crossref
Dídac Mauricio, Luigi Meneghini, Jochen Seufert, Laura Liao, Hongwei Wang, Liyue Tong, Anna Cali, Peter Stella, Paulo Carita & Kamlesh Khunti. (2017) Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes, Obesity and Metabolism 19:8, pages 1155-1164.
Crossref
Crossref